An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.

Hawkins O, Verma B, Lightfoot S, Jain R, Rawat A, McNair S, Caseltine S, Mojsilovic A, Gupta P, Neethling F, Almanza O, Dooley W, Hildebrand W, Weidanz J
J Immunol. 2011 186 (11): 6607-16

PMID: 21515791 · DOI:10.4049/jimmunol.1003995

MeSH Terms (24)

Amino Acid Sequence Animals Antibodies, Monoclonal Antibody Affinity Antibody Specificity Apoptosis Breast Neoplasms Carcinoma, Ductal, Breast Cell Line Cell Line, Tumor Cell Survival Dose-Response Relationship, Drug Female HLA-A2 Antigen HLA-A Antigens Humans Kinetics Macrophage Migration-Inhibitory Factors Mice Mice, Nude Peptides Prognosis Protein Binding Xenograft Model Antitumor Assays

Connections (1)

This publication is referenced by other Labnodes entities:

Links